JW Holdings Corporation (KRX:096760)

Market Cap	305.13B +43.8%
Revenue (ttm)	935.51B +1.1%
Net Income	43.19B -36.7%
EPS	617.51 -34.9%
Shares Out	69.19M
PE Ratio	7.14
Forward PE	n/a
Dividend	155.00 (3.63%)
Ex-Dividend Date	Mar 31, 2026

Volume	342,306
Average Volume	225,424
Open	4,285.00
Previous Close	4,275.00
Day's Range	4,265.00 - 4,445.00
52-Week Range	2,880.00 - 4,415.00
Beta	0.72
RSI	73.61
Earnings Date	Feb 6, 2026

About JW Holdings

JW Holdings Corporation, together with its subsidiaries, operates as a healthcare company in South Korea, the United States, Japan, China, and internationally. The company offers amino acid solutions, gastrointestinal agents, wound care, eye care, liver disease treatment, cold medicine, API, oral and topical analgesic, and other miscellaneous pharmaceutical products. It also offers hairdye, hair care, beauty care, and other cosmetics products; infant care system, gynecological examining table, sterilizer equipment, diagnostic imaging equipment,...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1945
• Employees: 127
• Stock Exchange: Korea Stock Exchange
• Ticker Symbol: 096760

Financial Performance

In 2024, JW Holdings's revenue was 887.71 billion, a decrease of -4.35% compared to the previous year's 928.07 billion. Earnings were 62.62 billion, an increase of 229.11%.